Clinical Trial Update: Study of Weekly LOC-paclitaxel Injection for Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 trial of weekly LOC-paclitaxel injections for melanoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• LOC-paclitaxel injection (LOC-paclitaxel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 1 | Status: TERMINATED